LEADER 01072nam0-2200313 --450 001 9910359759603321 005 20200109112355.0 010 $a978-88-452-9522-5 100 $a20200109d2019----kmuy0itay5050 ba 101 0 $aita$cita 102 $aIT 105 $a 001yy 200 1 $aQuesta è la storia$e[cinquant'anni di storia italiana attraverso le canzoni]$fUmberto Broccoli$ga cura di Patrizia Cavalieri$gintroduzione di Pier Luigi Vercesi 210 $aMilano$cBompiani$aFirenze$cGiunti$d2019 215 $a510 p.$cill.$d21 cm 300 $aSottotitolo della copertina 300 $aSegue: Indice dei nomi 610 0 $aMusica leggera$aDiffusione$aItalia$a1938-1988$aSociologia 676 $a306.4840945$v21$zita 700 1$aBroccoli,$bUmberto$f<1954->$0216698 702 1$aVercesi,$bPier Luigi$f<1961-> 702 1$aCavalieri,$bPatrizia 801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910359759603321 952 $aIX A 1495$b2495/2019$fFSPBC 959 $aFSPBC 996 $aQuesta è la storia$91569907 997 $aUNINA LEADER 02563nam 2200673 a 450 001 9910822629203321 005 20240313143147.0 010 $a9783527651085 010 $a352765108X 010 $a9781299241206 010 $a1299241204 010 $a9783527651115 010 $a352765111X 010 $a9783527651108 010 $a3527651101 035 $a(CKB)2670000000337445 035 $a(EBL)1123660 035 $a(SSID)ssj0000990601 035 $a(PQKBManifestationID)11544702 035 $a(PQKBTitleCode)TC0000990601 035 $a(PQKBWorkID)10987429 035 $a(PQKB)10284427 035 $a(Au-PeEL)EBL1123660 035 $a(CaPaEBR)ebr10662582 035 $a(CaONFJC)MIL455370 035 $a(OCoLC)826637765 035 $a(MiAaPQ)EBC1123660 035 $a(PPN)178875457 035 $a(Perlego)999796 035 $a(EXLCZ)992670000000337445 100 $a20130306d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAnalogue-based drug discovery III /$fedited by Ja?nos Fischer, C. Robin Ganellin and David P. Rotella 205 $a1st ed. 210 $aWeinheim, Germany $cWiley-VCH$d2013 215 $a1 online resource (405 p.) 300 $aDescription based upon print version of record. 311 08$a9783527330737 311 08$a3527330739 320 $aIncludes bibliographical references and index. 327 $apt. 1. General aspects -- pt. 2. Drug classes -- pt. 3. Case studies. 330 $aMost drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtu 606 $aDrug development 615 0$aDrug development. 676 $a615.19 701 $aFischer$b Ja?nos$0881301 701 $aGanellin$b C. R$g(C. Robin)$0881302 701 $aRotella$b David P$01661495 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910822629203321 996 $aAnalogue-based drug discovery III$94017436 997 $aUNINA